Home > Riviste > Giornale Italiano di Dermatologia e Venereologia > Fascicoli precedenti > Giornale Italiano di Dermatologia e Venereologia 2018 February;153(1) > Giornale Italiano di Dermatologia e Venereologia 2018 February;153(1):1-4

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

ORIGINAL ARTICLE   Freefree

Giornale Italiano di Dermatologia e Venereologia 2018 February;153(1):1-4

DOI: 10.23736/S0392-0488.17.05688-7

Copyright © 2017 EDIZIONI MINERVA MEDICA

lingua: Inglese

Serum levels of tumor necrosis factor-alpha in patients with psoriasis before, during and after narrow-band UVB phototherapy

Maria T. ROSSI 1, Marina VENTURINI 1 , Arianna ZANCA 1, Mariachiara ARISI 1, Marta FUSANO 1, Alessandra SOTTINI 2, Federico SERANA 2, Luisa IMBERTI 2, Piergiacomo CALZAVARA-PINTON 1

1 Department of Dermatology, Spedali Civili, University of Brescia, Brescia, Italy; 2 C.R.E.A. Lab, Department of Diagnostics, Spedali Civili, University of Brescia, Brescia, Italy


PDF


BACKGROUND: Narrow-band UVB (NB-UVB) phototherapy is widely used worldwide for moderate and severe psoriasis, which is a chronic autoimmune inflammatory disease characterized by skin infiltrates of Th1-, Th17- and Th22-cells releasing locally pro-inflammatory cytokines. We investigate serum levels of tumor necrosis factor-α (TNF-α) in psoriatic patients before and after NB-UVB phototherapy.
METHODS: Twenty-eight subjects with moderate/severe plaque type psoriasis were enrolled. The severity of skin involvement was rated according to the Psoriasis Area and Severity Index (PASI) score at baseline (T0) and after 4 (T1) and 12 (T2) weeks of NB-UVB treatment. At the same time points, blood samples were taken for evaluation of TNF-α levels. NB-UVB phototherapy was administered twice weekly on non-consecutive days until 12 weeks.
RESULTS: The median PASI score significantly decreased from 12.0 at baseline (T0), to 6.9 after 4 weeks (T1, P<0.001) and to 0 after 12 weeks (T2, P<0.001). TNF-a serum levels significantly increased in respect to the baseline after 12 weeks of therapy.
CONCLUSIONS: NB-UVB phototherapy is highly effective against psoriasis but, as it increases the TNF-α serum level, it seems unlikely that it can decrease the chronic inflammatory state that is thought to be responsible of the systemic co-morbidities of psoriasis.


KEY WORDS: Narrow-band imaging - Phototherapy - Psoriasis - Tumor necrosis factor-alpha

inizio pagina